ACNASE line adapts its strategy and focuses on digital media

Interactivity is the word of the moment in the relationship between companies and consumers. Following this trend, ACNASE, Biolab Pharmaceuticals' product line for treating blackheads and pimples, is betting on the digital channel, providing a new experience for young people. "Our target audience is predominantly on social networks. These young people use technology to get information, communicate and seek out rapid, direct responses from...

Portal Sindusfarma | 09/19/2019 Read more arrow_forward

Drug developed in partnership with USP supports Biolab's international presence

Established 22 years ago, Biolab is the youngest of Brazil's main pharmaceutical laboratories and is guided by innovation to accelerate its international presence. Behind the company's international strategy is its main drug, the antiemetic Vonau Flash (ondansetron), used for vomiting and nausea. Developed by the University of São Paulo (USP), with financial support from Biolab, the drug has been a success.   "This is the largest...

Portal Panorama Farmacêutico | 09/17/2019 Read more arrow_forward

Did you know that an anti-nausea medication accounts for 90% of the royalties received by USP?

08/19/2019 — Many people assume that research studies conducted by Brazil's public universities are of no practical use. Well, you should know that one of these studies conducted by the University of São Paulo (USP) found the "solution" to nausea and vomiting and has brought a return of around BRL 10 million in the last 13 years. Have you heard of the Vonau Flash? It is a medication whose patent was awarded to USP last year, and which...

https://bit.ly/2Zw7P3h | 08/19/2019 Read more arrow_forward

Innovation is what keeps our heart ticking

Biolab Farmacêutica's tribute to Cardiologist Day by Cleiton de Castro Marques Biolab is proud of featuring the field of Cardiology as one of its main areas of expertise. Caring for the heart takes a lot of knowledge, skill and commitment. That's why we foster positive and long-lasting relationships with our cardiologists. We have built and strengthened this commitment over time. The first medications ever manufactured by Biolab were for...

Up Pharma Magazine | 08/14/2019 Read more arrow_forward

Innovations from Biolab advance abroad

The first molecule 100% developed by Biolab and resulted from a radical innovation, dapaconazole will be tested in South Africa to treatment of multi resistant tuberculosis.  At the same time, the Brazilian pharmaceutical company is into dealing with international laboratories to offer a topical formulation of this potent anti-fungal, whose trade name is Zilt, in other countries. In Brazil, the ointment is expected to arrive at drugstores...

Valor Econômico Online | 07/01/2019 Read more arrow_forward

Hypertension accounts for half of stroke deaths and heart problems

04/24/2019 - In the National and World Day of Prevention and Fight against Arterial Hypertension, expert alerts to the various pitfalls for those who have high blood pressure National Arterial Hypertension Prevention and Control Day (April 26) and World Hypertension Day (May 17) are dates to alert people to the importance of controlling blood pressure. After all, it is one of the main factors for the onset of cardiovascular disease. According...

Portal Terra | 05/06/2019 Read more arrow_forward

Biolab Farmacêutica is a reference in the treatment of hypertension

April and May are marked by the Prevention and Fight against Hypertension. Biolab reinforces its commitment to take care of the population Biolab Farmacêutica performs the prescription of medicines for cardiology. This is the result of 22 years of dedicated care for the heart. A relationship of trust and respect, built with doctors and patients. The company started its operations in the segment with antihypertensive drugs and currently...

Media Company: Revista ABC Farma Online | 05/06/2019 Read more arrow_forward

Biolab invests in new factory and officially launches generic medicine unit

New industrial park in Minas Gerais had an investment of R$ 450 millions With 21 years of history dedicated to producing reference medicines, Biolab during Abradilan Conexão Farma Biolab officially launched Biolab Genéricos, line of medications that has the challenge of entering the market with a portfolio of exclusive and semi-exclusive products Abradilan Conexão Farma.  Biolab entering the generic medicinal product segment is...

Revista Guia da Farmácia | 04/03/2019 Read more arrow_forward

Laboratories advocate fair price to invest in Brazil

In the last few months, two multinational companies, Eli Lilly and Roche, announced the end of medicine production in Brazil, as part of the global reorganization of their industrial operations and portfolio. On the other hand, the local pharmaceutical industry has engaged in conversations with the federal government to seek rules that stimulate new projects and speed up investments. Between 2016 and 2018, laboratories with national capital...

Jornal Valor Econômico | 04/02/2019 Read more arrow_forward

Biolab endorses the José Ribeiro do Valle Award for Brazilian scientists

Biolab Farmacêutica supports and appreciates the initiatives of Brazilian researchers. For the 11th year in a row, the Company is the official sponsor of the "José Ribeiro do Valle" Award, promoted by the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFTE), which supports pharmacological studies and rewards young scientists committed to healthcare developments in the country. The award takes its name from Dr. José...

Facto Abifina Online Magazine | 10/01/2018 Read more arrow_forward

Ondansetron substance is the first recommendation for the treatment of vomiting and nausea during pregnancy

Information contained in the new guideline published by FEBRASGO The Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO) has just published a new guideline for the treatment of nausea and vomiting during pregnancy (HG). The document helps physicians by presenting new data, studies and the best treatment options for hyperemesis gravidarum, which afflicts the daily lives of about 85% of pregnant women. The new guideline...

Sogirgs Portal | 09/28/2018 Read more arrow_forward

Varicose veins - A health problem that can lead to serious complications

Few people know, but varicose veins can appear at any age, even in adolescence, and are a health problem that can bring complications such as thrombosis or open sores. Most of the time, the biggest complaints are related to the aesthetic aspect, causing embarrassment in men and women, but the fact is that varicose veins can even cause hospitalizations. In general, it is a problem that begins timidly and is therefore neglected by patients...

Revista UP Pharma | 08/20/2018 Read more arrow_forward

Energy, hotel, pharmaceutical industries and consumer goods sectors increase investments as Brazil chooses a new president

Equatorial Energia, which acquired Cepisa, distributor of Eletrobras in Piauí,  on an auction on Thursday, evaluates that it can obtain results faster in the company than in the power plants that the group already controls, in Maranhão (Cemar) and Pará (Celpa), also acquired in a difficult financial situation. In a conference call with shareholders and investors on the deal, Equatorial president Augusto Miranda said on Thursday...

Revista Exame Online | 08/10/2018 Read more arrow_forward

Biolab enters the generics market and evaluates purchase in Canada

Biolab, one of the largest pharmaceutical companies with national capital, has just entered a new market, that of generic drugs, with revenue estimated at over BRL 150 million in 2019. The company, which is about to inaugurate its BRL 450 million factory in Pouso Alegre (Minas Gerais), is also entering the central nervous system (CNS) segment and has been eyeing assets for sale in Canada to potentially establish its first production unit...

Valor Econômico | 07/04/2018 Read more arrow_forward

Are you going to play any sport? Be careful of your articulations

Practicing physical activities brings a lot of benefits to the body, since it improves the cardiopulmonary and muscle conditioning by reducing the risk of heart and metabolic diseases, in addition to improving the energy and reducing the emotional distress. However, regardless of the chosen modality, the medical follow-up and cautions are required for those who want to play any regular physical activity and avoid articular, muscle, among...

FOLHA DO ABC | 07/02/2018 Read more arrow_forward

Brazilian Society of Pediatrics releases guide for nausea and vomit treatment indicating the antiemetic drug ondansetron

The Brazilian Society of Pediatrics prepared the practical guide "Evidências para o Manejo de Náusea e Vômitos em Pediatria [Evidences on how to Handle Nausea and Vomit in Pediatrics]", in order to assist pediatricians to establish an accurate diagnosis and the most appropriate conduct for children presenting vomits due to different causes. Vomit is always anguishing for the child and the family. It is a common symptom for a number of...

SNIFBRASIL | 06/22/2018 Read more arrow_forward

Biolab Farmacêutica disseminates knowledge to medical professionals at the SOCESP 2018 Conference

Leading Brazilian cardiovascular prescription medicine company Biolab Farmacêutica provides ongoing Medical Education to attendants at the XXXIX São Paulo State Cardiology Society Conference, featuring renowned panelists and workshops: Extended Cardiovascular Continuum: Relationship between Atherosclerosis and Artery Age May 31st, 12:50 P.M, Conference Room 7, Blue Sector. Moderator: Dr. Francisco Fonseca, cardiology professor at the...

SINDUSFARMA | 05/30/2018 Read more arrow_forward

PHARMACEUTICAL PURCHASE

The pharmaceutical lab Biolab acquired the Brazilian operation of Actavis, a company of the Israeli group Teva that acts mainly in the production of medicines with action in the nervous system. The transaction amount has not been disclosed. “The discussions with Teva started in January as the group is making adjustments to its global operation,” said Cleiton de Castro Marques, purchaser CEO. With the acquisition, Biolab seeks to grow...

FOLHA DE S PAULO NEWSPAPER, MERCADO ABERTO/SP | 04/26/2018 Read more arrow_forward

An aiding technology in fighting cholesterol

One of the greatest benefits provided is not interfering with blood sugar, which makes it particularly suitable for diabetic and pre-diabetic people, and also does not affect retroviral cocktails and may be used by HIV patients. High levels of blood fat cause cholesterol indexes (LDL) to rise above recommended values, with ideal values around 50mg/dL, which may cause various and severe diseases, with over 50% risk of heart attacks and 25%...

Jornal Agora MS Online | Dourados, MS | 03/20/2018 Read more arrow_forward

Does crossing your legs cause varicose veins? Read more about the myths of this vascular problem

Varicose veins affect 50% of women, and cause more than aesthetic issues. Varicose veins affect about 50% of women and cause more than aesthetic issues, may affect quality of life and are even one of the main causes of work leave in Brazil. Even with so many cases, varicose veins are still surrounded by doubt and myths, which may prevent an early diagnosis. We talked to vascular surgeons Caio Focássio and Ivan Casella, in order to shed...

Jornal O Estado de S Paulo, E Mais | 03/11/2018 Read more arrow_forward

Diversity and Inclusion are challenges to the organization

An HR specialist believes that professionals should be attracted to career opportunities. More than complying with the Quotas Act, we should value diversity, promote social inclusion and nurture the potential of disabled professionals. So says Luciana Lourenço, HR superintendent at Biolab Farmacêutica, a company that holds opportunities for these people in various areas, including those that require a higher education level. She admits,...

Jornal O Amarelinho Online | 03/02/2018 Read more arrow_forward

Rejection to feeding? Your child may have GERD

Get to know the Gastroesophageal Reflux Disease It is common for babies to regurgitate, which is the return of milk to the mouth after the baby is done sucking, as soon as it is finished or some time later.  However, when this symptom reaches a whole new level and causes other problems, it should be investigated, as it could be a case of Gastroesophageal reflux disease (GERD). GERD is the condition in which bothersome symptoms and/or...

Portal Somos Mães de Primeira Viagem | 02/23/2018 Read more arrow_forward

Pressured by costs, companies join forces to cut health expenses

Costs with health insurance plans have become a nightmare for companies. In most of them, it represents the second largest expense with personnel, just losing to payroll. In some cases, even more. The disconnection between increased prices in general and the so-called medical inflation has started in the middle of last decade. However, it has become more noticeable from inflation control. Today, readjustments in health care insurance plans...

Jornal Valor Econômico, Empresas/SP | 02/01/2018 Read more arrow_forward

Irritability, food rejection and low weight gain? Your child may have Gastroesophageal Reflux Disease

It is common for babies to have regurgitation, popularly known as “gush”: milk returning to mouth after feed, at the time of breastfeeding or event some moment later. Although it is an uncomfortable situation, leading to family’s concern, regurgitation does not cause any risks to children, and should be understood as derived from the lack of maturity of digestive tract. However, when the level of this symptom is high and causes associated...

Sempre Materna | 01/16/2018 Read more arrow_forward

Intense vomits during pregnancy need treatment

The symptom can interfere in birth and development of the baby During gestation, nauseas and vomits in women are considered as normal symptoms; around 80% of pregnant women have these events. “In 85% of the cases, the solution is to simply change the habits, such as avoiding ingestion of liquids right after waking up and excluding fatty food, hot food and soda from diet”, explains Antonio Cabral, Doctor of Obstetrics from Unifesp and...

Diário do Nordeste | 11/07/2017 Read more arrow_forward

Biolab opens R&D site and plans to open a manufacturing plant in Canada

Biolab Farmacêutica is speeding up its internationalization project. The laboratory opens today the doors of the first research and development site (R&D) outside Brazil, in the province of Ontario, Canada, and in the next two or three years, it intends to open a drug manufacturing plant in that country. A result from investments of 56 million Canadian dollars (around US$ 45 million), the site will work as a technological platform...

Jornal Valor Econômico Impresso e Online | 10/31/2017 Read more arrow_forward

Osteoarthritis: a disease that reaches 15 million Brazilians

Osteoarthritis (OA), also known as arthrosis, is a degenerative and inflammatory joint disease, with no cure yet, which specially attacks knee, hip, spine and hands joints. The numbers of this disease are impressive: 15 million Brazilians have this pathology, according to Ministry of Health. The disease can have different causes: posttraumatic, age, genetic issues, excessive weight and obesity. The elderly is the age range most affected...

Jornal Diário de S. Paulo | 09/18/2017 Read more arrow_forward

Excessive folic acid during pregnancy can increase risk of autism

The substance in only one of the several factors that can contribute to the disorder, but correct dosage is essential to baby’s neurodevelopment. The consumption of folate - or folic acid synthetically - before and during pregnancy is essential to help closing the neural tube of babies, which will form central nervous system. The substance also prevents morphological issues, such as anencephaly, cleft lip and cleft palate, but excessive...

O Estado de S.Paulo | 09/04/2017 Read more arrow_forward

Biolab invests R$ 450 million in new manufacturing plant in Minas Gerais

The national pharmaceutical company Biolab, of the brothers Cleiton and Paulo de Castro Marques will invest R$ 450 million in a new industry complex in Pouso Alegre (MG). The unit will produce up to 200 million units per year and will triplicate the production capacity of the laboratory, which made R$ 1.25 billion last year. A lead company in sales and prescription of drugs for cardiology in Brazilian market, according to IMS Health consultancy,...

Jornal Valor Econômico - Empresas/SP | 07/24/2017 Read more arrow_forward

Biolab will invest R$ 450 million in a pharmaceutical manufacturing plant in MG

A LEAD IN SEGMENT OF PRESCRIPTION DRUGS IN CARDIOLOGY, THE LABORATORY WANTS TO SEEK CERTIFICATES TO SELL TO FOREIGN MARKET; WITH A NEW INVESTMENT, PHARMACEUTICAL COMPANY INTENDS TO STRENGTHEN EXPANSION STRATEGY IN VETERINARY SEGMENT National pharmaceutical company, Biolab, announced this Thursday, 20, an investment of R$ 450 million in a new manufacturing plant. The drug laboratory will be built in Pouso Alegre, south of Minas Gerais state,...

O Estado de S.Paulo | 07/24/2017 Read more arrow_forward

Technological innovation in national pharmaceutical industry

DANTE ALARIO JUNIOR | CSO - CHIEF SCIENTIFIC OFFICER AT BIOLAB FARMACÊUTICA  Year after year harping on the same topic, it means, on the need and importance of pharmaceutical industry, especially national industry, to have their own innovative developments, I am extremely happy to say that for many companies it has already become real. It is true that some companies are ahead (even designing new molecules) and others are in previous...

Revista Facto Abifina/SP | 07/18/2017 Read more arrow_forward

Corpore Sano: Is trauma a destiny?

Disinformation about trauma, its treatment and recovery prognosis is high. In order for health professionals to handle better and better with patients who underwent traumatic situations and who seek to return to the their lives before trauma, the psychologist Luíza Braga, a member of Associação Brasileira de Traumas (ABT), conducts the course “Is trauma a destiny? - Introduction to trauma theory.” The classes are on July 7 and 8,...

Jornal Diário do Nordeste Online/CE | 06/24/2017 Read more arrow_forward

Overweight is a reality in Brazil

The obesity represents the most growing nutritional problem in population noted in the last years. According to the last National Health Research (PNS), conducted by IBGE in partnership with Ministry of Health, almost 60% of Brazilians are overweighed. In waist size evaluation, 37.7% of Brazilians have increased circumference, which elevates the risks of cardiovascular diseases and diabetes. Bad food habits and high sugar consumption triggers...

Jornal O Estado de Minas Online/MG | 06/18/2017 Read more arrow_forward

One in every four Brazilians lives in the perfect scenario to a cardiac disease

At every two minutes, one Brazilian dies due to cardiac disease. Heart problems are responsible for more than 300 thousand deaths per year in the country, representing 30% of total. Data also highlights that heart diseases increasingly affects young people and cases in people aging 20 to 40 years old have doubled. According to Dr. Celso Amodeo, specialist of Instituto Dante Pazzanese de Cardiologia, heart diseases kill two times more than...

Portal Paraná | 06/13/2017 Read more arrow_forward

Long-term integrated public policies are the key to Brazil’s growth

Dante Alario Jr. has dedicated his life to pharmaceutical area. After the first job in his father’s industry, he established his own company - Sanus -, which posteriorly bought from Monsanto the Biolab brand, in 1997. Today, Alario is a technical-scientific director of the company and activist in the defense of national innovation, which led him to assume the position of pharmaceutical vice-president of ABIFINA. With this trajectory,...

Revista FACTO Abifina - número 50 | 01/18/2017 Read more arrow_forward

Rice protein is the new option for nutrition of children with cow’s milk allergy

FREQUENT CRYING, DIARRHEA, VOMIT, WEIGHT LOSS AND OCCURRENCE OF DERMATITIS ARE EVENTS CAUSED BY CMPA. Cow’s Milk Protein Allergy (CMPA) is the most frequent food allergy in the first phase of babies’ life, reaching 2 to 3% of the children aging less than 3 years old. The lack of an accurate diagnosis can increase the risks, and in extreme cases, it can even cause death from anaphylaxis, which is the most severe reaction caused by animal...

Portal Imirante | 11/16/2016 Read more arrow_forward

Schistosomiasis vaccine made in Brazil will have a decisive test in Senegal

Researchers from Brazil, Senegal and France has started a decisive test for their schistosomiasis vaccine, a disease caused by worms which poses a health risk to 200 million people around the world. Around 350 volunteers who live in regions strongly affected by the parasites should receive immunization, after initial evaluation, which indicated the vaccine is able to stimulate the organism to confront the invaders. For scientists of Fiocruz...

Jornal Folha de S Paulo Online/SP | 09/06/2016 Read more arrow_forward

Pharmaceutical Company Biolab and Marisol evaluate going to USA

Brazilian small- and medium-size companies have evaluated going to the United States. The demand had been already warmed up in the last years, but has started growing from 2014. The industry Marisol and the pharmaceutical company Biolab, one of the most innovative ones in the country, are among those with intention to enter into U.S. market, O Estado found out. "There was already a great demand, but uncertainties with the direction of the...

Jornal O Estado de S. Paulo/SP | 02/29/2016 Read more arrow_forward

Cade approves pharmaceutical joint venture

The Conselho Administrativo de Defesa Econômica (Cade) approved without constraints the joint venture between Pfizer and Orygen Biotecnologia, controlled by Biolab and Eurofarma, according to a procedural order published in Federal Official Gazette (DOU). The joint venture will manufacture and commercialize in Brazil up to five biosimilars: adalimumab, bevacizumab, infliximab, rituximab or trastuzumab based biosimilar. According to the...

Jornal DCI/SP | 01/29/2016 Read more arrow_forward

Folic acid has an impact on fetus health

In Brazil, 52% of women become pregnant without planning to. The data is from a research called “Nascer no Brasil” [Birth in Brazil] - National survey about delivery and birth, conducted by Fundação Oswaldo Cruz (Fiocruz) in 2014. In other words, more than half of the babies in the country do not benefit from protective effect of periconceptional supplementation (that precedes pregnancy) of folic acid or vitamin B9. This is because...

Jornal Estado de Minas | 01/18/2016 Read more arrow_forward

In Minas

Biolab Farmacêutica inaugurated the first phase of its new complex in the state of Minas Gerais, which should be concluded in 2019. Its turnover this year may raise 15% and reach R$ 1.5 million.  

Jornal Folha de S. Paulo/SP | 01/18/2016 Read more arrow_forward

Laboratories improve their operational management

A group formed by thirteen pharmaceutical companies installed in the country raised 15%, on average, the productivity in operational processes in 2015, from the adoption of an inedited system that allows comparing operational indicators. Named as BCO Farma and launched by sectorial entities, the new system allows pharmaceutical companies to compare their performance in different processes with the performance of their peers, without strategic...

Jornal Valor Econômico/SP | 01/07/2016 Read more arrow_forward

Runco talks about an innovative product arriving in Brazil for treatment of tendon and ligament injuries

On June 15, in Rio de Janeiro, Dr. José Luiz Runco – full member of SBOT (Brazilian Society of Orthopedics and Traumatology), former medical coordinator of Brazilian Soccer Team and e Flamengo Rowing Club - will present a great innovation in treatment of tendon and ligament injuries. The event will count on the presence of around 60 physicians with expertise in orthopedics, rheumatology and physiotherapy and will be held at Hotel Windsor...

Jornal 360 | 01/07/2016 Read more arrow_forward
Customer Service 0800 724 6522
faleconosco@biolabfarma.com.br
Be connected